Profil
Tatjana Momić
Zvanje:
Viši naučni saradnik
Direktni telefoni:
3408287
Lokal:
244-0871 / lok.1287
Naučna oblast:
1
Veće oblasti:
Organizaciona jedinica:
050
ZVANJA
M faktor
Kategorija | Broj | Koeficijent | Ukupno |
---|---|---|---|
M11 | 0 | 14 | 0 |
M12 | 0 | 10 | 0 |
M13 | 3 | 7 | 21 |
M14 | 0 | 4 | 0 |
M15 | 0 | 3 | 0 |
M16 | 0 | 2 | 0 |
M17 | 0 | 3 | 0 |
M18 | 0 | 2 | 0 |
M21a | 0 | 10 | 0 |
M21 | 10 | 8 | 80 |
M22 | 8 | 5 | 40 |
M23 | 1 | 3 | 3 |
M24 | 1 | 2 | 2 |
M25 | 0 | 1.5 | 0 |
M26 | 0 | 1 | 0 |
M27 | 0 | 0.5 | 0 |
M28a | 0 | 3.5 | 0 |
M28b | 0 | 2.5 | 0 |
M29a | 0 | 1.5 | 0 |
M29b | 0 | 1.5 | 0 |
M29v | 0 | 1 | 0 |
M31 | 0 | 3.5 | 0 |
M32 | 0 | 1.5 | 0 |
M33 | 8 | 1 | 8 |
M34 | 16 | 0.5 | 8 |
M35 | 0 | 0.3 | 0 |
M36 | 0 | 1.5 | 0 |
M41 | 0 | 7 | 0 |
M42 | 0 | 5 | 0 |
M43 | 0 | 3 | 0 |
M44 | 0 | 2 | 0 |
M45 | 0 | 1.5 | 0 |
M46 | 0 | 1 | 0 |
M47 | 0 | 0.5 | 0 |
M48 | 0 | 2 | 0 |
M49 | 0 | 1 | 0 |
M51 | 0 | 2 | 0 |
M52 | 0 | 1.5 | 0 |
M53 | 1 | 1 | 1 |
M54 | 0 | 0.2 | 0 |
M55 | 0 | 1 | 0 |
M56 | 0 | 0.3 | 0 |
M57 | 0 | 0.2 | 0 |
M61 | 0 | 1.5 | 0 |
M62 | 0 | 1 | 0 |
M63 | 0 | 1 | 0 |
M64 | 0 | 0.2 | 0 |
M65 | 0 | 0 | 0 |
M66 | 0 | 1 | 0 |
M67 | 0 | 0 | 0 |
M68 | 0 | 0 | 0 |
M69 | 0 | 0 | 0 |
M71 | 0 | 6 | 0 |
M72 | 0 | 3 | 0 |
M81 | 0 | 0 | 0 |
M82 | 0 | 0 | 0 |
M83 | 0 | 0 | 0 |
M84 | 0 | 0 | 0 |
M85 | 1 | 0 | 0 |
M86 | 0 | 0 | 0 |
M87 | 0 | 0 | 0 |
M91 | 2 | 0 | 0 |
M92 | 0 | 0 | 0 |
M93 | 0 | 0 | 0 |
M94 | 0 | 0 | 0 |
M95 | 0 | 0 | 0 |
M96 | 0 | 0 | 0 |
M97 | 0 | 0 | 0 |
M98 | 0 | 0 | 0 |
M99 | 0 | 0 | 0 |
M101 | 0 | 0 | 0 |
M102 | 0 | 0 | 0 |
M103 | 0 | 0 | 0 |
M104 | 0 | 0 | 0 |
M105 | 0 | 0 | 0 |
M106 | 0 | 0 | 0 |
M107 | 0 | 0 | 0 |
M108 | 0 | 0 | 0 |
M109 | 0 | 0 | 0 |
M110 | 0 | 0 | 0 |
M111 | 0 | 0 | 0 |
M112 | 0 | 0 | 0 |
M121 | 0 | 3 | 0 |
M122 | 0 | 2 | 0 |
M123 | 0 | 1 | 0 |
M124 | 0 | 1 | 0 |
Ukupno M faktor:
163
NI radovi
# | Naziv, Datum, Grupa, Vrsta | Godina | Autori | Status | Akcija |
---|---|---|---|---|---|
1 |
Disintegrin-based, synthetic cyclic KTS peptides as novel dual antagonists of α1β1/α2β1 integrins with antiangiogenic activity
Anti angiogenesis drug discovery & development , / , 2016 M10 | M13 |
2016 | Татјана Момић, , , , , , |
Odobren
|
|
2 |
Metal based compounds, modulators of Na,K-ATPase with anticancer activity
Regulation of Membrane Na+-K+ ATPase, Advances in Biochemistry in Health and Disease , / , 2016 M10 | M13 |
2016 | Tatjana G. Momić, Mirjana B. Čolović, Tamara D. Lazarević-Pašti, Vesna M. Vasić |
Odobren
|
|
3 |
Influence of organophosphorus pesticides on peroxidase and chlorination activity of human myeloperoxidase
PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY , / , 2013 M20 | M21 |
2013 | Тамара Лазаревић-Пашти, Татјана Момић, Милош Радојевић, Весна Васић |
Odobren
|
|
4 |
Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs
Current Medicinal Chemistry , / , 2017 M20 | M21 |
2017 | Тамара Лазаревић-Пашти, Андреја Лесковац, Татјана Момић, Сандра Петровић, Весна Васић |
Odobren
|
|
5 |
Myeloperoxidase-mediated oxidation of organophosphorus pesticides as a pre-step in their determination by AChE based bioanalytical methods
MICROCHIMICA ACTA , / , 2010 M20 | M21 |
2010 | Тамара Лазаревић-Пашти, Татјана Момић, Антоније Онјиа, Љубодраг Вујисић, Весна Васић |
Odobren
|
|
6 |
Near infrared optical visualization of epidermal growth factor receptors levels in COLO205 colorectal cell line, orthotopic tumor in mice and human biopsies
International Journal of Molecular Sciences , / , 2013 M20 | M21 |
2013 | G. Cohen, S. Lecht, M. Oron-Herman, Т. Момић, A. Nissan, P. Lazarovici |
Odobren
|
|
7 |
Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with anti-platelet aggregation activity
Drug Design, Development and Therapy , / , 2015 M20 | M21 |
2015 | Татјана Момић, J. Katzehendler, , E. Noy, H. Senderowitz, J.A. Eble, C. Marcinkiewicz, , P. Lazarovici |
Odobren
|
|
8 |
Vimocin and Vidapin, cyclic KTS peptides, dual antagonists of α1β1/α2β1 integrins with antiangiogenic activity
Journal of Pharmacology and Experimental Therapeutics , / , 2014 M20 | M21 |
2014 | Татјана Момић, J. Katzehendler, , , , E. Noy, H. Senderowitz, J. A. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
9 |
Cytocompatibility of novel extracellular matrix protein analogs of biodegradable polyester polymers derived from α-hydroxy amino acids
Journal of biomaterials science. Polymer edition , / , 2014 M20 | M22 |
2014 | , , G. Cohen, , Татјана Момић, , , J. Katzhendler, , P. Lazarovici, |
Odobren
|
|
10 |
Identification of α2β1 integrin inhibitor VP-i with anti-platelet properties in the venom of Vipera palaestinae
Toxicon , / , 2013 M20 | M22 |
2013 | , Татјана Момић, , E. Shai, , D. Varon, C. Marcinkiewicz, P. Lazarovici, J.A. Eble |
Odobren
|
|
11 |
The effects of a chactoid scorpion venom and its purified toxins on rat blood pressure and mast cells histamine release
Toxins , / , 2013 M20 | M22 |
2013 | K. Ettinger, G. Cohen, Т. Момић, P. Lazarovici |
Odobren
|
|
12 |
Vixapatin (VP12), a C-type lectin-protein from Vipera xantina palestinae venom: Characterization as a novel nti-angiogenic compound
Toxins , / , 2012 M20 | M22 |
2012 | Татјана Момић, G. Cohen, , F.T. Arlinghaus, J.A. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
13 |
Pharmacological aspects of Vipera xantina palestinae venom
Toxins , / , 2011 M20 | M24 |
2011 | Татјана Момић, F.T. Arlinghaus, H. Arien-Zakay, J. Katzhendler, J.A. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
14 |
Medicinal chemistry approach for solid phase synthesis of peptide mimetics of viperistatin disintegrin as lead compounds for α1/α2 integrin receptors
Journal of Peptide Science , / , 2012 M30 | M33 |
2012 | Татјана Момић, J. Katzhendler, C. Marcinkiewicz, J.A. Eble, P. Lazarovici |
Odobren
|
|
15 |
Oxidation of some organophosphate pesticides with enzyme myeloperoxidase
10th International Conference of Fundamental and Applied Aspects of Physical Chemistry , / , 2010 M30 | M33 |
2010 | Т. Лазаревић-Пашти, Т. Момић, В. Васић |
Odobren
|
|
16 |
Visual detection of quercetin using gold nanoparticles
7th Workshop Specific Methods for Food Safety and Quality, September 22nd, , Belgrade, Serbia , 2021 M30 | M33 |
2021 | M. Nemoda, M. Pavlović, M. Stoiljković, and T. Momić |
Odobren
|
|
17 |
Medicinal chemistry approach for solid phase synthesis of peptide mimetics of viperistatin disintegrin as lead compounds for α1/α2 integrin receptors
32nd European Peptide Symposium , / , 2012 M30 | M34 |
2012 | Татјана Момић, J. Katzhendler, C. Marcinkiewicz, A.J. Eble, P. Lazarovici |
Odobren
|
|
18 |
Synthetic cyclic KTS peptides, Vimocin and Vidapin as dual antagonists of α1β1/α2β1 integrins with antiangiogenic activity
The 2nd Congress of the Serbian Association for Cancer Research , / , 2015 M30 | M34 |
2015 | Татјана Момић, J. Katzehendler, E. Noy, H. Senderowitz, J.A. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
19 |
Vimocin and Vidapin, cyclic KTS peptides, are dual, partial antagonists of α1β1/α2β1 integrins with antiangiogenic activity
7th International Conference on Tumor Microenvironment: Progression, Therapy and Prevention , / , 2015 M30 | M34 |
2015 | P. Lazarovici, Татјана Момић, J. Katzehendler, O. Benny, E. Noy, H. Senderowitz, J.A. Eble, C. Marcinkiewicz |
Odobren
|
|
20 |
Vixapatin, a C-type lectin-protein from Vipera xantina palestinae venom can be used as a pharmacological tool for development of novel CNS drugs selective for α2β1 integrin.
The 22nd Israel Society for Neuroscience (ISFN) Annual Meeting , / , 2013 M30 | M34 |
2013 | Т. Момић, J. Katzhendler, R. Reich, J. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
21 |
VP12 - pharmacological tool for development of novel drug selective for α2β1 integrin
Annual Meeting of the Israel Society for Physiology and Pharmacology , / , 2012 M30 | M34 |
2012 | Татјана Момић, F.T. Arlinghaus, H. Arien-Zakay, J. Katzhendler, J.A. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
22 |
VP12 – Detection of α2β1 integrin inhibitor with anti-platelet properties in the venom of Vipera palaestinae
Annual Meeting of the Israel Society for Physiology and Pharmacology , / , 2013 M30 | M34 |
2013 | Т. Момић, F. Arlinghaus, N. Abu Ammar, E. Shai, G. Spectre, D. Varon, J. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
23 |
VP12 – Pharmacological tool for development of novel CNS drugs selective for α2β1 integrin
The 5th Triennial Seminar: Brain Malfunction and Degeneration , / , 2012 M30 | M34 |
2012 | Татјана Момић, F.T. Arlinghaus, , J. Katzhendler, J.A. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
24 |
VIPERISTATIN-DERIVED PEPTIDES AND USES THEREOF
VIPERISTATIN-DERIVED PEPTIDES AND USES THEREOF , / , 2013 M90 | M91 |
2013 | Т. Момић, H. Arien-Zakay, J. Katzhendler, J. Eble, C. Marcinkiewicz, P. Lazarovici |
Odobren
|
|
25 |
PEPTIDOMIMETIC ANTAGONISTS FOR PREVENTION AND TREATMENT OF THROMBOTIC DISEASES AND DISORDERS
PEPTIDOMIMETIC ANTAGONISTS FOR PREVENTION AND TREATMENT OF THROMBOTIC DISEASES AND DISORDERS , / , 2014 M90 | M91 |
2014 | Татјана Момић, J. Katzehendler, E. Shai, D. Varon, C. Marcinkiewicz, P. Lazarovici |
Odobren
|